11 – 16 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2019
-
Mark
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
(
- Contribution to journal › Article
-
Mark
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease : A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
(
- Contribution to journal › Article
- 2018
-
Mark
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
(
- Contribution to journal › Article
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients : A phase 2 randomised clinical trial
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »